复星医药

- 600196

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
复星医药(600196) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入2,046,281.271,015,725.534,139,953.963,070,011.912,139,519.26
营业收入2,046,281.271,015,725.534,139,953.963,070,011.912,139,519.26
二、营业总成本1,940,887.97952,243.354,128,407.693,028,427.922,063,204.19
营业成本1,046,338.55507,770.642,159,530.881,577,952.121,069,852.05
营业税金及附加16,422.259,244.1727,125.5419,796.2113,757.30
销售费用426,627.08224,023.09971,223.74722,668.19507,129.56
管理费用206,443.17100,226.91437,490.72316,893.34204,500.76
财务费用58,883.3328,021.8298,432.3475,607.8854,536.65
研发费用186,173.5982,956.72434,604.47315,510.17213,427.87
资产减值损失----------
公允价值变动收益-28,239.79-2,013.73-42,737.9680,633.6438,737.39
投资收益106,176.6333,555.80350,199.26218,241.73147,338.07
其中:对联营企业和合营企业的投资收益84,132.0333,032.50218,484.87149,592.24102,226.34
汇兑收益----------
三、营业利润192,928.68102,136.41330,750.79334,219.78268,261.08
加:营业外收入2,885.65931.415,712.404,959.072,420.59
减:营业外支出2,694.251,225.4310,006.409,933.205,134.67
其中:非流动资产处置损失----------
四、利润总额193,120.08101,842.39326,456.79329,245.65265,547.00
减:所得税费用38,146.8823,220.2736,950.4563,864.7061,024.47
五、净利润154,973.2078,622.12289,506.34265,380.95204,522.53
归属于母公司所有者的净利润122,479.8660,973.36238,626.58228,306.59177,747.19
少数股东损益32,493.3417,648.7550,879.7637,074.3626,775.34
六、每股收益
基本每股收益(元/股)0.46000.23000.89000.86000.6700
稀释每股收益(元/股)0.46000.23000.89000.85000.6700
七、其他综合收益11,241.999,115.423,185.7238,304.7247,560.58
八、综合收益总额166,215.1987,737.54292,692.06303,685.68252,083.11
归属于母公司所有者的综合收益总额132,133.6868,523.31235,082.38250,227.09203,629.48
归属于少数股东的综合收益总额34,081.5119,214.2357,609.6853,458.5948,453.63
下载全部历史数据到excel中 返回页顶